Search
Your selection
NoneFilter by category
Filter by category
Filter by category
Filter by category
Filter by content type
Filter by content year
Filter by form group
Filter by type
Filter by tags
Vaxart Announces Share Purchase Agreement for up to $25 Million with Lincoln Park Capital
April 17, 2026 - … in amounts as described in the agreement. Vaxart maintains full control over the timing and amount of any sales, Lincoln … in amounts as described in the agreement. Vaxart maintains full control over the timing and amount of any sales, Lincoln … in amounts as described in the agreement. Vaxart maintains full control over the timing and amount of any sales, Lincoln …
Vaxart Provides Business Update and Reports Full Year 2025 Financial Results
March 12, 2026 - … Vaxart Provides Business Update and Reports Full Year 2025 Financial Results Vaxart Provides Business Update and Reports Full Year 2025 Financial Results March 12, 2026 Earnings … its business update and financial results for the full year 2025. “Our COVID-19 program reached a major …
Thu, 03/12/2026 - 16:30 - … Vaxart, Inc. Full Year 2025 Business Update and Financial Results Conference Call Vaxart, Inc. Full Year 2025 Business Update and Financial Results … Vaxart, Inc. Full Year 2025 Business Update and Financial Results … Vaxart, Inc. Full Year 2025 Business Update and Financial Results …
… Listen to Webcast March 12, 2026 4:30 PM EDT Vaxart, Inc. Full Year 2025 Business Update and Financial Results … Listen to Webcast March 12, 2026 4:30 PM EDT Vaxart, Inc. Full Year 2025 Business Update and Financial Results …
Vaxart to Host Upcoming Conference Calls
March 3, 2026 - … to Host Upcoming Conference Calls March 3, 2026 General Full year 2025 business update and financial results … it will host two upcoming webcast conference calls. Full Year 2025 Business Update and Financial Results Vaxart … a business update and report financial results for the full year ended December 31, 2025, after the market close …
Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results
November 13, 2025 - … based on Vaxart’s delivery platform. Vaxart will retain full operational and financial responsibility for the oral … based on Vaxart’s delivery platform. Vaxart will retain full operational and financial responsibility for the oral … based on Vaxart’s delivery platform. Vaxart will retain full operational and financial responsibility for the oral …
Dynavax Enters Exclusive License Agreement for Vaxart’s Novel Oral COVID-19 Vaccine Program
November 5, 2025 - … based on Vaxart’s delivery platform. Vaxart will retain full operational and financial responsibility for the oral … to delivering a robust data package that could unlock the full potential of this collaboration and demonstrate the … based on Vaxart’s delivery platform. Vaxart will retain full operational and financial responsibility for the oral …
Vaxart Provides Business Update and Reports Second Quarter 2025 Financial Results
August 13, 2025 - … the preclinical studies in a peer-reviewed forum when the full study analysis is complete. Financial Results for the … the preclinical studies in a peer-reviewed forum when the full study analysis is complete. Financial Results for the … the preclinical studies in a peer-reviewed forum when the full study analysis is complete. Financial Results for the …
Vaxart CEO Issues Letter to Stockholders
August 8, 2025 - … showed 100% protection in a robust ferret challenge model. Full results will be published upon completion of our … showed 100% protection in a robust ferret challenge model. Full results will be published upon completion of our … showed 100% protection in a robust ferret challenge model. Full results will be published upon completion of our …
… Fireside Chat March 12, 2026 4:30 PM EDT Vaxart, Inc. Full Year 2025 Business Update and Financial Results … Fireside Chat March 12, 2026 4:30 PM EDT Vaxart, Inc. Full Year 2025 Business Update and Financial Results …